CITIUS PHARMAC Stock Forecast - Accumulation Distribution
| 47N Stock | EUR 3.29 0.00 0.00% |
CITIUS Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of CITIUS PHARMAC's historical fundamentals, such as revenue growth or operating cash flow patterns.
CITIUS |
| Check CITIUS PHARMAC Volatility | Backtest CITIUS PHARMAC | Trend Details |
CITIUS PHARMAC Trading Date Momentum
| On November 14 2024 CITIUS PHARMAC DL was traded for 8.12 at the closing time. The highest daily price throughout the period was 8.12 and the lowest price was 8.12 . There was no trading activity during the period 1.0. Lack of trading volume on 11/14/2024 added to the next day price reduction. The daily price change to closing price of the next trading day was 21.32% . The overall trading delta to current closing price is 55.62% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare CITIUS PHARMAC to competition |
Other Forecasting Options for CITIUS PHARMAC
For every potential investor in CITIUS, whether a beginner or expert, CITIUS PHARMAC's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. CITIUS Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in CITIUS. Basic forecasting techniques help filter out the noise by identifying CITIUS PHARMAC's price trends.CITIUS PHARMAC Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CITIUS PHARMAC stock to make a market-neutral strategy. Peer analysis of CITIUS PHARMAC could also be used in its relative valuation, which is a method of valuing CITIUS PHARMAC by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
CITIUS PHARMAC DL Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of CITIUS PHARMAC's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of CITIUS PHARMAC's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
CITIUS PHARMAC Market Strength Events
Market strength indicators help investors to evaluate how CITIUS PHARMAC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CITIUS PHARMAC shares will generate the highest return on investment. By undertsting and applying CITIUS PHARMAC stock market strength indicators, traders can identify CITIUS PHARMAC DL entry and exit signals to maximize returns.
CITIUS PHARMAC Risk Indicators
The analysis of CITIUS PHARMAC's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in CITIUS PHARMAC's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting citius stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.81 | |||
| Standard Deviation | 7.77 | |||
| Variance | 60.4 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Other Information on Investing in CITIUS Stock
CITIUS PHARMAC financial ratios help investors to determine whether CITIUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CITIUS with respect to the benefits of owning CITIUS PHARMAC security.